Le Lézard3h
HepQuant to Present at Key Liver Conferences to Highlight Applications of HepQuant DuOtm - a Quantitative Liver Health Test
HepQuant, LLC continues to expand clinical availability of the HepQuant DuO test to liver specialists in clinical practice, and will present eight abstracts at key upcoming liver conferences, ...
Le Lézard3h
GRIN Therapeutics Receives FDA Orphan Drug Designation for Radiprodil for the Treatment of GRIN-Related Neurodevelopmental Disorder
GRIN Therapeutics, Inc., a leader in the development of therapies to treat serious neurodevelopmental disorders, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug ...